Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 100 of 423 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 05/31/06
Due: 05/31/07
Phase: N/A
Priority: Normal
Start: 05/31/04
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 01/31/95
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/97
End: 08/31/01
Due: 08/31/02
Phase: N/A
Priority: Normal
Start: 07/01/08
End: 11/30/19
Due: 11/30/20
Estimation of the Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans
Phase: N/A
Priority: Normal
Start: 06/30/01
End: 03/31/03
Due: 03/31/04
Phase: N/A
Priority: Normal
Start: 12/31/87
End: 12/31/03
Due: 12/31/04
Phase: N/A
Priority: Normal
Start: 08/18/06
End: 03/30/15
Due: 03/30/16
Phase: N/A
Priority: Normal
Start: 03/31/02
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 06/30/03
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 04/30/02
End: 04/30/07
Due: 04/30/08
Phase: N/A
Priority: Normal
Start: 10/25/01
End: 06/23/16
Due: 06/23/17
Phase: N/A
Priority: Normal
Start: 03/04/19
End: 01/03/40
Due: 01/03/41
Phase: N/A
Priority: Normal
Start: 08/20/09
End: 03/05/13
Due: 03/05/14
Phase: N/A
Priority: Normal
Start: 02/29/04
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 11/08/11
End: 09/01/17
Due: 09/01/18
Phase: N/A
Priority: Normal
Start: 07/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/07
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 09/30/92
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/18/09
End: 11/27/13
Due: 11/27/14
Phase: N/A
Priority: Normal
Start: 06/30/06
End: 11/30/08
Due: 11/30/09
Phase: N/A
Priority: Normal
Start: 10/31/02
End: 01/31/06
Due: 01/31/07